These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11422825)

  • 1. Transjugular intrahepatic portosystemic shunt prior to renal transplantation in a child with autosomal-recessive polycystic kidney disease and portal hypertension: A case report.
    Benador N; Grimm P; Lavine J; Rosenthal P; Reznik V; Lemire J
    Pediatr Transplant; 2001 Jun; 5(3):210-4. PubMed ID: 11422825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcome of transjugular intrahepatic portosystemic shunt for portal hypertension in autosomal recessive polycystic kidney disease.
    Verbeeck S; Mekhali D; Cassiman D; Maleux G; Witters P
    Dig Liver Dis; 2018 Jul; 50(7):707-712. PubMed ID: 29622386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic renal failure and portal hypertension--is portosystemic shunt indicated?
    Tsimaratos M; Cloarec S; Roquelaure B; Retornaz K; Picon G; Chabrol B; Guys JM; Sarles J; Nivet H
    Pediatr Nephrol; 2000 Aug; 14(8-9):856-8. PubMed ID: 10955945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morbidity from congenital hepatic fibrosis after renal transplantation for autosomal recessive polycystic kidney disease.
    Khan K; Schwarzenberg SJ; Sharp HL; Matas AJ; Chavers BM
    Am J Transplant; 2002 Apr; 2(4):360-5. PubMed ID: 12118859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of severe azathioprine-induced hepatic veno-occlusive disease in a kidney-transplanted patient with transjugular intrahepatic portosystemic shunt.
    Azoulay D; Castaing D; Lemoine A; Samuel D; Majno P; Reynes M; Charpentier B; Bismuth H
    Clin Nephrol; 1998 Aug; 50(2):118-22. PubMed ID: 9725784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individualized concept for the treatment of autosomal recessive polycystic kidney disease with end-stage renal disease.
    Miura K; Sato Y; Yabuuchi T; Kaneko N; Ishizuka K; Chikamoto H; Akioka Y; Nawashiro Y; Hisano M; Imamura H; Miyai T; Sakamoto S; Kasahara M; Fuchinoue S; Okumi M; Ishida H; Tanabe K; Hattori M
    Pediatr Transplant; 2020 May; 24(3):e13690. PubMed ID: 32128974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New approaches to the autosomal recessive polycystic kidney disease patient with dual kidney-liver complications.
    Telega G; Cronin D; Avner ED
    Pediatr Transplant; 2013 Jun; 17(4):328-35. PubMed ID: 23593929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of symptomatic portal hypertension].
    Krajina A; Hůlek P; Eliás P; Michl A; Zizka J; Nozicka J; Vanásek T; Lojík M; Niangová I; Volfová M; Pozler O; Erben J; Papík Z; Bures J
    Cas Lek Cesk; 1996 Sep; 135(18):584-8. PubMed ID: 8998798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transjugular intrahepatic portosystemic shunt in the management of Budd Chiari syndrome.
    Olliff SP
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1151-4. PubMed ID: 17033433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of portal hypertension with transjugular intrahepatic portosystemic shunt: guidelines for referring suitable patients].
    Astrup LB; Clemmesen JO; Frevert SC; Larsen FS; Nielsen DT; Schlichting P; Vilstrup H
    Ugeskr Laeger; 2007 Aug; 169(34):2758-61. PubMed ID: 17878010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital hepatic fibrosis and autosomal recessive polycystic kidney disease.
    Srinath A; Shneider BL
    J Pediatr Gastroenterol Nutr; 2012 May; 54(5):580-7. PubMed ID: 22197937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transjugular intrahepatic portosystemic shunt for intractable colonic bleeding in a patient with cirrhosis.
    Malki S; Allen R; Pavli P
    J Gastroenterol Hepatol; 2000 Aug; 15(8):962-3. PubMed ID: 11022842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transjugular intrahepatic portosystemic shunt for portal hypertension in a patient with Caroli disease.
    Qi B; Tong M; Zhang L; Yuan Y
    Asian J Surg; 2023 Jul; 46(7):2888-2889. PubMed ID: 36781318
    [No Abstract]   [Full Text] [Related]  

  • 14. Pregnancies after transjugular intrahepatic portosystemic shunt for noncirrhotic portal hypertension.
    Nicolas C; Ferrand E; d'Alteroche L; Ayoub J; Bastides F; Potin J; Perarnau JM
    Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):488-90. PubMed ID: 24526236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current diagnosis and management of post-transjugular intrahepatic portosystemic shunt refractory hepatic encephalopathy.
    Pereira K; Carrion AF; Martin P; Vaheesan K; Salsamendi J; Doshi M; Yrizarry JM
    Liver Int; 2015 Dec; 35(12):2487-94. PubMed ID: 26332169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome using the fluency stent graft for transjugular intrahepatic portosystemic shunt in patients with portal hypertension.
    Wu X; Ding W; Cao J; Fan X; Li J
    Am Surg; 2013 Mar; 79(3):305-12. PubMed ID: 23461959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment with transjugular intrahepatic portosystemic shunt (TIPS) of recurrent massive rectal bleeding due to portal hypertension: case report.
    Yeşilkaya Y; Çil B; Peynircioğlu B; Şimşek H
    Turk J Gastroenterol; 2013; 24(4):363-6. PubMed ID: 24254271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension.
    Parker R
    Clin Liver Dis; 2014 May; 18(2):319-34. PubMed ID: 24679497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Follow-up study of 116 cases of transjugular intrahepatic portosystemic shunt in the treatment of cirrhotic portal hypertension].
    Liu MH; Zhou F; Wang XB; Chen LP; Li GZ; Zhao Q
    Zhonghua Gan Zang Bing Za Zhi; 2018 Aug; 26(8):596-600. PubMed ID: 30317791
    [No Abstract]   [Full Text] [Related]  

  • 20. Emerging issues in the use of transjugular intrahepatic portosystemic shunt (TIPS) for management of portal hypertension: time to update the guidelines?
    Riggio O; Ridola L; Lucidi C; Angeloni S
    Dig Liver Dis; 2010 Jul; 42(7):462-7. PubMed ID: 20036625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.